103 related articles for article (PubMed ID: 18309939)
1. Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
De Palma R; Liberati A; Ciccone G; Bandieri E; Belfiglio M; Ceccarelli M; Leoni M; Longo G; Magrini N; Marangolo M; Roila F;
J Clin Oncol; 2008 Mar; 26(7):1033-9. PubMed ID: 18309939
[TBL] [Abstract][Full Text] [Related]
2. [Fundamentals and results of cytostatic chemotherapy in some of the most common solid tumors].
Brugger SA; Huber H
Acta Med Austriaca; 1999; 26(3):83-8. PubMed ID: 10520375
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy in the elderly: making the right decision.
Muss HB; Biganzoli L; Sargent DJ; Aapro M
J Clin Oncol; 2007 May; 25(14):1870-5. PubMed ID: 17488985
[TBL] [Abstract][Full Text] [Related]
4. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
5. Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center.
Epstein RJ; Leung TW; Mak J; Cheung PS
Cancer Invest; 2006; 24(4):367-73. PubMed ID: 16777688
[TBL] [Abstract][Full Text] [Related]
6. [Anticancer chemotherapy in the elderly: a review of the literature].
Debrix I; Avenin D; André T; Abbas F; Gligorov J; Milleron B; Lotz JP; Becker A
Bull Cancer; 2008 May; 95 FMC Onco():F37-43. PubMed ID: 18511365
[TBL] [Abstract][Full Text] [Related]
7. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
[TBL] [Abstract][Full Text] [Related]
8. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system.
Atkins D; Briss PA; Eccles M; Flottorp S; Guyatt GH; Harbour RT; Hill S; Jaeschke R; Liberati A; Magrini N; Mason J; O'Connell D; Oxman AD; Phillips B; Schünemann H; Edejer TT; Vist GE; Williams JW;
BMC Health Serv Res; 2005 Mar; 5(1):25. PubMed ID: 15788089
[TBL] [Abstract][Full Text] [Related]
9. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
12. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
13. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
14. The influence of a gene expression profile on breast cancer decisions.
Henry LR; Stojadinovic A; Swain SM; Prindiville S; Cordes R; Soballe PW
J Surg Oncol; 2009 May; 99(6):319-23. PubMed ID: 19204954
[TBL] [Abstract][Full Text] [Related]
15. Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance.
Parmelli E; Papini D; Moja L; Bandieri E; Belfiglio M; Ciccone G; De Palma R; Leoni M; Longo G; Magrini N; Moschetti I; Liberati A
Ann Oncol; 2011 Jan; 22(1):188-194. PubMed ID: 20605933
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy principles for breast, prostate, colon and lung cancer.
Keppen M
S D Med; 2010; Spec No():52-6. PubMed ID: 20397492
[No Abstract] [Full Text] [Related]
17. How to use a clinical practice guideline.
Dahm P; Yeung LL; Gallucci M; Simone G; Schünemann HJ
J Urol; 2009 Feb; 181(2):472-9. PubMed ID: 19084846
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
Besse B; Le Chevalier T
J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
[No Abstract] [Full Text] [Related]
19. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
20. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
Vilmar A; Sørensen JB
Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
